BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21965570)

  • 21. Yersinia YopE is targeted for type III secretion by N-terminal, not mRNA, signals.
    Lloyd SA; Norman M; Rosqvist R; Wolf-Watz H
    Mol Microbiol; 2001 Jan; 39(2):520-31. PubMed ID: 11136471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. YopB and YopD constitute a novel class of Yersinia Yop proteins.
    Håkansson S; Bergman T; Vanooteghem JC; Cornelis G; Wolf-Watz H
    Infect Immun; 1993 Jan; 61(1):71-80. PubMed ID: 8418066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
    Viboud GI; So SS; Ryndak MB; Bliska JB
    Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane.
    Holmström A; Petterson J; Rosqvist R; Håkansson S; Tafazoli F; Fällman M; Magnusson KE; Wolf-Watz H; Forsberg A
    Mol Microbiol; 1997 Apr; 24(1):73-91. PubMed ID: 9140967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A bacterial secreted translocator hijacks riboregulators to control type III secretion in response to host cell contact.
    Kusmierek M; Hoßmann J; Witte R; Opitz W; Vollmer I; Volk M; Heroven AK; Wolf-Watz H; Dersch P
    PLoS Pathog; 2019 Jun; 15(6):e1007813. PubMed ID: 31173606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yersinia controls type III effector delivery into host cells by modulating Rho activity.
    Mejía E; Bliska JB; Viboud GI
    PLoS Pathog; 2008 Jan; 4(1):e3. PubMed ID: 18193942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YopN Is Required for Efficient Effector Translocation and Virulence in Yersinia pseudotuberculosis.
    Bamyaci S; Ekestubbe S; Nordfelth R; Erttmann SF; Edgren T; Forsberg Å
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate immune recognition of Yersinia pseudotuberculosis type III secretion.
    Auerbuch V; Golenbock DT; Isberg RR
    PLoS Pathog; 2009 Dec; 5(12):e1000686. PubMed ID: 19997504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of the Yersinia enterocolitica type III secretion chaperone SycD in complex with a peptide of the minor translocator YopD.
    Schreiner M; Niemann HH
    BMC Struct Biol; 2012 Jun; 12():13. PubMed ID: 22708907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live imaging of Yersinia translocon formation and immune recognition in host cells.
    Rudolph M; Carsten A; Kulnik S; Aepfelbacher M; Wolters M
    PLoS Pathog; 2022 May; 18(5):e1010251. PubMed ID: 35604950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetratricopeptide repeats in the type III secretion chaperone, LcrH: their role in substrate binding and secretion.
    Edqvist PJ; Bröms JE; Betts HJ; Forsberg A; Pallen MJ; Francis MS
    Mol Microbiol; 2006 Jan; 59(1):31-44. PubMed ID: 16359316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD.
    Sarker MR; Neyt C; Stainier I; Cornelis GR
    J Bacteriol; 1998 Mar; 180(5):1207-14. PubMed ID: 9495760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translocation of the Yersinia YopE and YopH virulence proteins into target cells is mediated by YopB and YopD.
    Rosqvist R; Persson C; Håkansson S; Nordfeldt R; Wolf-Watz H
    Contrib Microbiol Immunol; 1995; 13():230-4. PubMed ID: 8833841
    [No Abstract]   [Full Text] [Related]  

  • 34. Macrophage innate immune responses delineate between defective translocon assemblies produced by
    Farag SI; Francis MK; Gurung JM; Wai SN; Stenlund H; Francis MS; Nadeem A
    Virulence; 2023 Dec; 14(1):2249790. PubMed ID: 37621095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The RACK1 signaling scaffold protein selectively interacts with Yersinia pseudotuberculosis virulence function.
    Thorslund SE; Edgren T; Pettersson J; Nordfelth R; Sellin ME; Ivanova E; Francis MS; Isaksson EL; Wolf-Watz H; Fällman M
    PLoS One; 2011 Feb; 6(2):e16784. PubMed ID: 21347310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic analysis of the formation of the Ysc-Yop translocation pore in macrophages by Yersinia enterocolitica: role of LcrV, YscF and YopN.
    Marenne MN; Journet L; Mota LJ; Cornelis GR
    Microb Pathog; 2003 Dec; 35(6):243-58. PubMed ID: 14580388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of predicted transmembrane domains for type III translocation, pore formation, and signaling by the Yersinia pseudotuberculosis YopB protein.
    Ryndak MB; Chung H; London E; Bliska JB
    Infect Immun; 2005 Apr; 73(4):2433-43. PubMed ID: 15784589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact.
    Harmon DE; Murphy JL; Davis AJ; Mecsas J
    J Bacteriol; 2013 May; 195(10):2244-54. PubMed ID: 23475976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of SycD, the chaperone of the Yersinia Yop translocators YopB and YopD.
    Neyt C; Cornelis GR
    Mol Microbiol; 1999 Jan; 31(1):143-56. PubMed ID: 9987117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression hierarchy in the Yersinia type III secretion system established through YopD recognition of RNA.
    Chen Y; Anderson DM
    Mol Microbiol; 2011 May; 80(4):966-80. PubMed ID: 21481017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.